Cargando…
Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index
In 1990, 215 patients with operable breast cancer were entered into a prospective study of the prognostic significance of five biochemical markers and 15 other factors (pathological/chronological/patient). After a median follow-up of 6.6 years, there were 77 recurrences and 77 deaths (59 breast canc...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364292/ https://www.ncbi.nlm.nih.gov/pubmed/12085248 http://dx.doi.org/10.1038/sj.bjc.6600335 |
_version_ | 1782153918199889920 |
---|---|
author | Hawkins, R A Tesdale, A L Prescott, R J Forster, T McIntyre, M A Baker, P Jack, W J L Chetty, U Dixon, J M Killen, M E Hulme, M J Miller, W R |
author_facet | Hawkins, R A Tesdale, A L Prescott, R J Forster, T McIntyre, M A Baker, P Jack, W J L Chetty, U Dixon, J M Killen, M E Hulme, M J Miller, W R |
author_sort | Hawkins, R A |
collection | PubMed |
description | In 1990, 215 patients with operable breast cancer were entered into a prospective study of the prognostic significance of five biochemical markers and 15 other factors (pathological/chronological/patient). After a median follow-up of 6.6 years, there were 77 recurrences and 77 deaths (59 breast cancer-related). By univariate analysis, patient outcome related significantly to 13 factors. By multivariate analysis, the most important of nine independent factors were: number of nodes involved, steroid receptors (for oestrogen or progestogen), age, clinical or pathological tumour size and grade. Receptors and grade exerted their influence only in the first 3 years. Progestogen receptors (immunohistochemical) and oestrogen receptors (biochemical) were of similar prognostic significance. The two receptors were correlated (r=+0.50, P=0.001) and displaced each other from the analytical model but some evidence for the additivity of their prognostic values was seen when their levels were discordant. British Journal of Cancer (2002) 87, 8–14. doi:10.1038/sj.bjc.6600335 www.bjcancer.com © 2002 Cancer Research UK |
format | Text |
id | pubmed-2364292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23642922009-09-10 Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index Hawkins, R A Tesdale, A L Prescott, R J Forster, T McIntyre, M A Baker, P Jack, W J L Chetty, U Dixon, J M Killen, M E Hulme, M J Miller, W R Br J Cancer Clinical In 1990, 215 patients with operable breast cancer were entered into a prospective study of the prognostic significance of five biochemical markers and 15 other factors (pathological/chronological/patient). After a median follow-up of 6.6 years, there were 77 recurrences and 77 deaths (59 breast cancer-related). By univariate analysis, patient outcome related significantly to 13 factors. By multivariate analysis, the most important of nine independent factors were: number of nodes involved, steroid receptors (for oestrogen or progestogen), age, clinical or pathological tumour size and grade. Receptors and grade exerted their influence only in the first 3 years. Progestogen receptors (immunohistochemical) and oestrogen receptors (biochemical) were of similar prognostic significance. The two receptors were correlated (r=+0.50, P=0.001) and displaced each other from the analytical model but some evidence for the additivity of their prognostic values was seen when their levels were discordant. British Journal of Cancer (2002) 87, 8–14. doi:10.1038/sj.bjc.6600335 www.bjcancer.com © 2002 Cancer Research UK Nature Publishing Group 2002-07-01 2002-07-15 /pmc/articles/PMC2364292/ /pubmed/12085248 http://dx.doi.org/10.1038/sj.bjc.6600335 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Hawkins, R A Tesdale, A L Prescott, R J Forster, T McIntyre, M A Baker, P Jack, W J L Chetty, U Dixon, J M Killen, M E Hulme, M J Miller, W R Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index |
title | Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index |
title_full | Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index |
title_fullStr | Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index |
title_full_unstemmed | Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index |
title_short | Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index |
title_sort | outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index |
topic | Clinical |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364292/ https://www.ncbi.nlm.nih.gov/pubmed/12085248 http://dx.doi.org/10.1038/sj.bjc.6600335 |
work_keys_str_mv | AT hawkinsra outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex AT tesdaleal outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex AT prescottrj outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex AT forstert outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex AT mcintyrema outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex AT bakerp outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex AT jackwjl outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex AT chettyu outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex AT dixonjm outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex AT killenme outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex AT hulmemj outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex AT millerwr outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex |